Abstract
Background: Only few epidemiological studies have examined the associations between dietary intake of flavonoids and the risk of ovarian and endometrial cancers. Although preliminary, there are some suggestive findings about the protective effects of high consumption of flavone luteolin, flavonol kaempferol, and total or individual isoflavones (daidzein, genistein, glycitein) against ovarian tumorigenesis. Results about the possible role of flavonoid intake on endometrial cancer risk are even more scarce and inverse association may be restricted only to certain female subgroups, such as to lean or postmenopausal women consuming high doses of isoflavones. Keywords: Flavonoids, isoflavones, anticancer action, epidemiological findings, ovarian cancer, endometrial cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
